Latest filing published 01 Jul 2021 for Graphite Bio, Inc., €92k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Joshua Lehrer-Graiwer: trading record in brief
Joshua Lehrer-Graiwer, listed as chief executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Global Blood Therapeutics, Inc. and LENZ Therapeutics, Inc. Between 14 November 2019 and 29 June 2021, the trades on record add up to 54 filings.
On the market, this insider has only sold: 21 sales, €3.0M in total. The rest of the record consists of 4 share grants and 28 option exercises.
The latest filing, published on 1 July 2021, reports a transaction in LENZ Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Joshua Lehrer-Graiwer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 374,013 shares@ US$0.30100.0% of flowCommon StockSEC:0000899243-21-027011:0
1 of 1 declaration
